This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Second Reply to Letter to the Editor re: “Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting”
Prostate Cancer and Prostatic Diseases Open Access 28 August 2019
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ehdaie B, Carlsson S. Reply to ‘Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting’. Prostate Cancer Prostatic Dis. 2018.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
White, J., Tutrone, R.F. Reply to Letter to the Editor re: ‘Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting’. Prostate Cancer Prostatic Dis 21, 604 (2018). https://doi.org/10.1038/s41391-018-0063-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41391-018-0063-8
This article is cited by
-
Second Reply to Letter to the Editor re: “Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting”
Prostate Cancer and Prostatic Diseases (2019)